background
sinc
may
exposur
popul
beij
china
result
increas
respiratori
ill
limit
inform
avail
etiolog
clinic
characterist
influenzalik
ill
ili
ensu
adult
follow
pandem
method
clinic
epidemiolog
data
ili
adult
collect
total
throat
swab
test
twelv
respiratori
virus
use
multiplex
rtpcr
clinic
characterist
influenza
outpati
versu
testneg
patient
compar
use
pearson
mannwhitney
u
test
swab
test
viru
isol
consult
rate
ili
compar
result
one
two
viru
detect
sampl
influenza
viru
flua
account
virus
present
frequenc
less
cough
significantli
associ
influenza
viru
infect
posit
rate
flua
consist
chang
ili
rate
period
signific
reduct
incid
ili
conclus
exposur
impact
typic
influenza
season
peak
although
flua
remain
predomin
viru
beij
symptomat
cough
associ
flua
infect
posit
rate
influenza
viru
consist
chang
ili
rate
period
signific
reduct
incid
ili
compar
influenza
viru
season
acut
respiratori
infect
associ
signific
morbid
mortal
adult
everi
winter
similar
countri
peak
influenza
season
china
associ
higher
health
care
util
china
weekli
case
influenzalik
ill
ili
acutecar
set
throughout
countri
report
chines
nation
influenza
center
cnic
mainli
attribut
influenza
viru
predominantli
influenza
viru
flua
influenza
b
viru
flub
addit
influenza
virus
respiratori
virus
also
caus
ili
symptom
adult
human
respiratori
syncyti
viru
hrsv
human
parainfluenza
virus
hpiv
includ
parainfluenza
viru
type
rhinoviru
adenoviru
human
coronavirus
human
metapneumoviru
thu
multipl
respiratori
virus
may
circul
among
adult
caus
influenza
symptom
inconsist
whether
certain
symptom
use
distinguish
specif
infect
gener
accept
symptom
specif
viral
infect
studi
attempt
identifi
sign
symptom
specif
associ
influenza
viru
virus
definit
conclus
drawn
ili
data
ili
rate
ili
count
extent
reflect
influenza
activ
ili
attack
rate
may
higher
among
adult
pandem
china
ili
data
larger
hospit
deliv
valuabl
inform
could
use
monitor
onset
epidem
peke
univers
peopl
hospit
pkuph
affili
teach
hospit
peke
univers
nonprofit
health
care
institut
provid
except
care
environ
patient
famili
extend
care
patient
nation
pkuph
receiv
approxim
outpati
case
annual
patient
area
beyond
beij
mainli
northern
china
account
forti
percent
figur
infecti
diseas
depart
pkuph
nation
influenza
surveil
sentinel
unit
studi
focus
chang
ili
present
howev
studi
report
whether
chang
viral
etiolog
distribut
well
clinic
epidemiolog
characterist
ili
follow
pandem
studi
focus
etiolog
epidemiolog
characterist
adult
ili
symptom
influenza
pandem
beij
research
studi
involv
healthrel
patient
intervent
studi
conduct
accord
principl
guidelin
express
declar
helsinki
approv
less
minim
risk
research
research
ethic
committe
pkuph
written
consent
form
requir
approv
inform
sheet
use
instead
consent
form
detail
inform
given
patient
inform
consent
receiv
swab
sampl
collect
data
analyz
anonym
human
influenzalik
ill
ili
case
clinic
defin
sudden
onset
fever
cough
andor
sore
throat
less
three
day
durat
laboratoryconfirm
evid
anoth
etiolog
ili
case
defin
fluaposit
ilicas
rtpcr
result
throat
swab
sampl
posit
influenza
viru
coinfect
diagnos
one
viru
test
posit
rtpcr
studi
popul
includ
adult
year
sought
medic
attent
fever
outpati
servic
pkuph
nation
influenza
surveil
sentinel
unit
june
may
data
collect
time
medic
consult
use
case
report
form
adult
patient
met
ilicas
definit
criteria
data
collect
includ
demographi
clinic
observ
symptom
chronic
medic
condit
treatment
temperatur
laboratori
test
result
rtpcrposit
patient
addit
use
telephon
interview
determin
treatment
comorbid
vaccin
statu
durat
fever
variabl
analyz
data
shown
tabl
singl
throat
swab
use
steril
rayon
swab
collect
ilipati
receiv
antivir
drug
swab
immedi
place
viru
transport
media
tube
sampl
frozen
within
hour
analyz
total
clinic
specimen
analyz
viral
rna
extract
pcr
amplif
viral
rna
extract
ml
viral
transport
medium
contain
swab
use
qiaamp
viral
rna
mini
kit
qiagen
viral
rna
mini
extract
kit
germani
follow
manufactur
instruct
extract
rna
use
templat
perform
rtpcr
reaction
use
reversetranscriptas
polymeras
chain
reaction
rtpcr
kit
fermenta
shenzhen
cdna
compound
action
revers
transcriptas
random
primer
rna
rtpcr
amplif
system
follow
total
rna
ml
random
primer
ml
buffer
ml
mm
dntp
ml
rna
inhibitor
ml
ml
revers
transcriptas
ad
depc
treat
water
ml
condit
use
twostep
rtpcr
follow
primari
rtpcr
incub
minut
cool
ice
minut
follow
minut
minut
cool
ice
minut
store
collect
test
viru
use
multiplex
pcr
rtpcr
product
test
per
manufactur
instruct
follow
virus
influenza
b
viru
respiratori
syncyti
viru
rsv
human
coronavirus
parainfluenza
viru
enteroviru
rhinovirus
adenovirus
final
metapneumoviru
use
leagu
respiratori
viru
multipl
pcr
detect
kit
neurohemin
hangzhou
pcr
amplif
system
follow
cdna
templat
ml
primer
ml
solut
ml
master
mix
ml
pcr
carri
pcr
amplifi
condit
follow
minut
follow
cycl
minut
minut
minut
extens
minut
follow
storag
collect
sampl
divid
two
group
test
group
sampl
test
presenc
adenoviru
adv
metapneumoviru
mpv
human
coronaviru
parainfluenza
viru
piv
type
group
b
sampl
test
presenc
influenza
b
viru
human
coronaviru
rhinoviru
hrv
ab
rsv
ba
flu
pcr
product
analyz
agaros
gel
electrophoresi
stain
ethidium
bromid
visual
uv
light
box
pcr
product
compar
marker
b
band
gel
determin
size
specimen
test
decid
whether
swab
infect
respiratori
viru
viral
cultur
type
section
throat
swab
specimen
randomli
select
period
ship
icebox
beij
center
diseas
control
prevent
cdc
viru
isol
confirm
isol
subtyp
flua
perform
sampl
viru
isol
process
use
mdck
cell
line
posit
result
follow
haemagglutin
inhibit
test
use
refer
antisera
recommend
manual
http
wwwwho
neg
decreas
reaction
refer
antisera
occur
isol
viru
rtpcr
sequenc
use
clarifi
infect
data
enter
databas
analyz
use
spss
softwar
version
spss
chicago
il
usa
continu
distribut
variabl
compar
fluaposit
ilicas
fluaneg
ilicas
use
student
ttest
data
normal
distribut
mannwhitney
u
test
nonnorm
distribut
categor
data
proport
compar
use
pearson
x
chisquar
test
order
evalu
associ
variabl
fluaposit
case
univari
level
continu
distribut
variabl
recategoris
binari
variabl
univari
analysi
use
x
allow
calcul
odd
ratio
confid
interv
p
consid
statist
signific
clinic
characterist
summar
tabl
among
patient
test
rtpcr
influenza
viru
respiratori
virus
detect
complet
inform
concern
clinic
present
routin
examin
avail
patient
total
fluaposit
case
fluaneg
case
data
number
sampl
clinic
univari
characterist
p
valu
odd
ratio
well
confid
interv
ci
fluaposit
fluaneg
case
seen
tabl
comparison
fluaneg
ilicas
patient
cough
like
report
patient
whose
rtpcr
test
posit
influenza
viru
tabl
patient
infect
flua
experienc
cough
patient
infect
virus
virus
free
clinic
characterist
sore
throat
headach
appear
frequent
infect
flua
viru
noninfect
differ
statist
signific
fluainfect
patient
present
mean
temperatur
ci
averag
commenc
day
admiss
iqr
approxim
fluainfect
patient
report
hyperpyrexia
temperatur
median
age
patient
test
posit
influenza
year
iqr
male
signific
differ
male
femal
rate
differ
neutrophil
percentag
whose
rtpcr
test
posit
influenza
test
neg
clinic
univari
characterist
influenzaa
viru
ilicas
patient
show
tabl
rtpcrposit
patient
undertook
telephon
followup
collect
data
tabl
fluaposit
case
receiv
antivir
treatment
within
three
day
onset
symptom
rtpcrposit
white
cell
count
l
n
n
n
among
swab
collect
sampl
test
posit
least
one
respiratori
viru
multiplex
rtpct
tempor
distribut
viral
agent
confirm
case
test
rtpcr
shown
figur
influenza
virus
flu
predomin
viral
etiolog
compris
total
specimen
confirm
case
june
may
beij
almost
fluposit
specimen
flua
case
account
convers
two
influenza
b
virusposit
sampl
identifi
among
sampl
virus
present
frequenc
less
hrv
adv
three
case
individu
hrcv
two
case
hrsv
one
case
hmpv
fluc
hpiv
detect
even
thought
primer
design
detect
strain
addit
seven
sampl
total
number
specimen
test
posit
one
viru
coinfect
hrsva
hrv
two
case
flua
one
case
hrv
flua
one
case
hrsva
flua
one
case
combin
hrsva
hrv
flua
two
case
ident
viru
coinfect
confirm
amplif
primer
specif
viru
decreas
number
patient
seek
medic
attent
observ
figur
overal
level
outpati
consult
less
particularli
may
decemb
may
emerg
beij
capac
outpati
servic
infecti
diseas
depart
pkuph
increas
rapidli
peak
number
attend
outpati
depart
occur
novemb
outpati
volum
declin
reach
normal
level
third
month
number
outpati
remain
rel
stabl
volum
increas
novemb
decemb
peak
januari
addit
signific
reduct
percentag
outpati
consult
ili
detect
north
china
figur
pandem
highest
weekli
ili
rate
case
per
consult
week
figur
ili
rate
rel
stabl
base
data
avail
weekli
ili
surveil
system
north
china
percentag
patient
visit
ili
peak
late
januari
rtpcr
consid
one
sensit
specif
test
diagnosi
influenza
addit
multiplex
pcr
method
detect
panel
respiratori
virus
coinfect
simultan
studi
pharyng
swab
specimen
collect
ili
casepati
strictli
compli
chines
cdc
standard
gener
popul
beij
china
expos
novel
pandem
influenza
viru
sinc
mid
may
accord
chines
cdc
may
confirm
case
death
pandem
influenza
report
nationwid
mainland
china
studi
approxim
sampl
posit
least
one
viru
consist
result
studi
alon
incid
fluposit
specimen
high
may
reflect
possibl
sampl
collect
bias
toward
patient
exhibit
ili
clinic
symptomat
definit
influenza
identifi
potenti
influenza
case
word
influenzalik
ill
casedefinit
make
influenza
virus
viru
commonli
detect
studi
humantoswin
transmiss
pandem
influenza
viru
conclud
human
ili
case
definit
high
specif
low
sensit
flua
influenza
virus
usual
account
much
greater
proport
posit
specimen
influenzalik
ill
adult
respiratori
virus
peak
season
total
sampl
total
number
rtpcr
posit
case
reveal
presenc
coinfect
five
fluaposit
sampl
viral
coinfect
observ
includ
one
coinfect
hrcv
juli
one
hrv
novemb
one
hrsva
one
hrsva
hrv
januari
one
hrsva
hrv
februari
popul
challeng
multipl
infecti
agent
may
result
epidem
restructur
variou
virus
rate
ili
indic
trend
influenza
pandem
beij
locat
temper
zone
northern
hemispher
influenza
typic
peak
season
year
beij
experi
one
peak
influenza
activ
peak
occur
decemberjanuari
next
year
ahead
novemb
peak
ili
increas
acut
respiratori
infect
ari
due
influenza
support
season
pattern
highprob
ili
low
level
respiratori
syncyti
viru
infect
laboratori
result
influenza
season
influenza
season
season
pattern
ili
activ
observ
influenza
activ
peak
late
januari
beij
compar
previou
pandem
year
lower
outpati
number
observ
figur
overal
rate
influenzalik
ill
outpati
lower
season
pandem
influenza
season
figur
result
requir
fever
definit
ili
calcul
incid
may
underestim
true
incid
ili
cohort
studi
show
posit
rate
influenza
viru
consist
chang
ili
rate
period
ilicas
patient
infect
june
januari
compar
previou
year
age
flua
patient
rang
year
mean
age
year
older
age
ilicas
patient
mean
age
year
specimen
viral
etiolog
identifi
viru
detect
may
reflect
fact
virus
known
caus
respiratori
symptom
test
therefor
remaind
may
caus
respiratori
virus
microorgan
could
also
addit
pathogen
posit
specimen
also
possibl
virus
could
detect
due
low
level
shed
studi
attempt
identifi
symptom
associ
influenza
infect
howev
wide
known
clinic
diagnosi
influenza
straightforward
difficult
find
symptom
combin
symptom
specif
influenza
found
cough
significantli
associ
influenza
consist
result
boivin
ohmit
monto
report
cough
associ
posit
pcr
test
influenza
popul
influenza
preval
within
commun
specimen
collect
influenza
season
beij
cough
appear
specif
influenza
cohort
also
consist
view
call
et
al
believ
fever
cough
specif
influenza
among
elderli
individu
influenza
viru
circul
area
find
statist
signific
differ
occurr
fever
temperatur
fluaposit
group
fluaneg
group
x
studi
involv
age
group
demonstr
muscl
joint
pain
headach
associ
influenza
howev
find
statist
signific
differ
occurr
muscl
joint
pain
headach
fluaposit
group
fluaneg
group
x
studi
limit
test
etiolog
acut
respiratori
ill
perform
gener
known
respiratori
virus
bacteria
microorgan
caus
respiratori
ill
influenzalik
symptom
without
doubt
microorgan
could
addit
pathogen
posit
specimen
conclus
affect
typic
influenza
season
peak
although
flua
remain
predomin
viru
beij
symptomat
cough
associ
flua
infect
posit
rate
influenza
viru
consist
chang
ili
rate
period
signific
reduct
incid
ili
compar
find
studi
may
facilit
clinic
discrimin
influenza
viru
infect
well
provid
data
distribut
inform
virolog
surveil
influenza
